Rockwell Medical reports positive data on iron deficiency drug(Reuters) - Rockwell Medical Inc reported positive results from a clinical study of its iron deficiency treatment for patients on hemodialysis. The company's shares, which rose 25 percent in early trading, later pared some gains to trade up 4 percent at $6.70. The study was not part of Rockwell's pivotal program to get U.S. Food and Drug Administration approval for the drug, company spokesman David Connolly said. He said Rockwell would use the results to market the drug if approved. ...
Source: Rockwell Medical reports positive data on iron deficiency drug (http://news.yahoo.com/rockwell-medical-reports-positive-data-iron-deficiency-drug-160753232.html)